Iceland· IS-EU/1/22/1630/001

Kimmtrak

A antineoplastic agents product containing tebentafuspum inn, registered in Iceland by Immunocore Ireland Limited. The same ATC class is registered in 6 of our 19 countries.

ATC L01

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedKimmtrakATCL01REGISTER NO.IS-EU/1/22/1630/001PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Tebentafuspum inn is registered in 6 of 19 countries.

Countries holding a registration under ATC L01 (antineoplastic agents), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 3 of them publish a price we can compare per daily dose

Tebentafuspum inn · ATC L01

6 / 19 countries

  • Canada
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Tebentafuspum INN
Manufacturer
Immunocore Ireland Limited
Country
Iceland (IS)
ATC code
L01
ATC class
ANTINEOPLASTIC AGENTS
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tebentafuspum inn in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tebentafuspum inn products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Liechtenstein · Kimmtrak
  • Norway · Kimmtrak

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6cce4c0b-8529-44ae-82e7-e6f07aa6ed84
GET /v1/drugs/6cce4c0b-8529-44ae-82e7-e6f07aa6ed84?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Innrennslisþykkni, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "L01",
  "marketed": true,
  "strength": "100 míkróg/0,5 ml",
  "ma_number": "EU/1/22/1630/001",
  "substance": "Tebentafuspum INN",
  "other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "44652"
}

See everything about tebentafuspum inn.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.